Drug intelligence / Profile preview

Biolik Tuberculin PPD-L

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Recombinant Proteins and Enzymes
Administration
Intradermal
01

Overview

Biolik Tuberculin PPD-L is a diagnostic reagent developed by Biolik Biopharmaceutical for the detection of tuberculosis infection. The active ingredient is allergen-tuberculoprotein, a purified protein derivative (PPD) derived from heat-killed cultures of human and bovine *Mycobacterium tuberculosis*. It is administered intradermally via the Mantoux test. The reagent works by triggering a delayed-type hypersensitivity (Type IV) reaction in individuals who have been previously sensitized to the bacteria through natural infection or BCG vaccination. This reaction is characterized by local skin inflammation, induration, and papule formation at the injection site. It is primarily used for diagnosing latent tuberculosis infection, screening high-risk populations, and determining the necessity of BCG vaccination.

Brand names
БІОЛІК Туберкулін ППД-ЛBiolik Tuberculin PPD-L
Other names
Туберкулін ППД-ЛTuberculin PPD-LAllergen-tuberculoproteinPurified Protein Derivative

Beyond the preview

Go deeper on Biolik Tuberculin PPD-L.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biolik Tuberculin PPD-L.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call